{"id":223,"date":"2010-03-31T14:21:40","date_gmt":"2010-03-31T05:21:40","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2010\/03\/31\/2004\/"},"modified":"2010-03-31T14:21:40","modified_gmt":"2010-03-31T05:21:40","slug":"2004","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20100331223\/","title":{"rendered":"2004\u5e74\uff08\u5e73\u621016\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n

–<\/p>\n

\u3010\u539f\u8457\u3011<\/h4>\n
    \n
  1. Takechi S, Yamaguchi T, Nomura H, Minematsu T, Nakayama T. Growth inhibition and mutagenesis induced in Escherichia coli<\/em> by dihydropyrazine with DNA strand-cleaving activity. Mutat Res. 2004;560: 49-55. (May)<\/li>\n
  2. Okayama A, Stuver SO, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller NE, Hsieh C, Tachibana N, Tsubouchi H. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia\/Lymphoma in asymptomatic carriers. Int J Cancer. 2004;110:621-625. (July)<\/li>\n
  3. Kotani T, Umeki K, Kawano J, Suganuma T, Yamamoto I, AratakeY, Ichiba Y, Furujo M. A novel missense mutation in the thyroid peroxidase gene, R175Q, resulting in insufficient cell surface enzyme in two siblings. Clin Pediatr Endocrinol. 2004;13: 37-46. (July)<\/li>\n
  4. Umeki K, Kawano J, Yamamoto I, Aratake Y, Kotani T. Comparative analysis and characterization of mutated thyroid peroxidases with disturbance expressed on the cell surface. Mol Cell Endocrinol. 2004;223:77-84. (August)<\/li>\n
  5. Birmann BM, Mueller NE, Okayama A, Hsieh CC, Tachibana N, Tsubouchi H, Lennette ET, Harn D, Stuver SO. Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults. Cancer Epidemiol Biomarkers Prev 2004;13:1385-1391. (August)<\/li>\n
  6. Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis. 2004;190:1605-1609. (September)<\/li>\n
  7. \u5ca1\u5c71\u662d\u5f66, \u4f50\u3005\u6728\u9686, \u677e\u5143\u4fe1\u5f18. \u30ec\u30b8\u30aa\u30cd\u30e9\u96c6\u56e3\u611f\u67d3\u8abf\u67fb\u3088\u308a\u5b66\u3093\u3060\u3053\u3068. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c.\u30002004;66:3-7. (10\u6708)<\/li>\n
  8. Gao G, Stuber SO, Okayama A, Tsubouchi H, Mueller NE, Tabor E. The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies:a comparison of subjects with and without liver cancer. J Viral Hepatitis. 2005;12:46-50. (January).<\/li>\n
  9. Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y, Okayama A, Hamada K, Okabe H, Murakami Y, Tsubouchi H, Morishita K. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 2005;105:1204-1213. (February)<\/li>\n
  10. Kubuki Y, Suzuki M, Sasaki H, Toyama T, Yamashita K, Maeda K, Ido A, Matsuoka H, Okayama A, Nakanishi T, Tsubouchi H. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk Lymphoma. 2005;46:3,393-399. (March)<\/li>\n
  11. \u67ff\u5143\u7531\u9999, \u5965\u91ce\u3081\u3050\u307f, \u4e95\u4e0a\u6b66\u5fd7, \u5b88\u7530\u653f\u5ba3, \u68ee\u5c71\u6676\u5b50, \u8352\u6b66\u516b\u8d77. \u8840\u6027\u7d30\u80de\u8a3a\u6750\u6599\u306b\u304a\u3051\u308b\u6a19\u672c\u4f5c\u88fd\u6cd5\u306e\u691c\u8a0e. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:33-37. (1\u6708)<\/li>\n
  12. \u5965\u91ce\u3081\u3050\u307f, \u67ff\u5143\u7531\u9999, \u4e95\u4e0a\u6b66\u5fd7, \u5b88\u7530\u653f\u5ba3, \u68ee\u5c71\u6676\u5b50, \u8352\u6b66\u516b\u8d77. \uff24\u30c0\u30a4\u30de\u30fc\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:46-49. (1\u6708)<\/li>\n
  13. \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u83c5\u6587\u6075, \u6885\u6728\u4e00\u7f8e, \u5cf6\u7530\u96c5\u5df3. \u672c\u9662\u306b\u304a\u3051\u308b\u7dd1\u81bf\u83cc\u5206\u96e2\u682a\u306e\u611f\u53d7\u6027\u52d5\u5411\u306b\u3064\u3044\u3066. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:63-65. (1\u6708)<\/li>\n
  14. \u4e2d\u6751\u80b2\u4ee3, \u9b3c\u585a\u8056\u5b50, \u5b88\u7530\u653f\u5ba3, \u6e05\u5c71\u548c\u662d. \u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u533b\u5e2b\u4f1a\u7cbe\u5ea6\u7ba1\u7406\u8abf\u67fb\u3078\u306e\u53d6\u308a\u7d44\u307f. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:66-68. (1\u6708)<\/li>\n<\/ol>\n

    \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
      \n
    1. \u9ad8\u57ce\u4e00\u90ce, \u7530\u4e2d\u5f26\u4e00, \u4f50\u3005\u6728\u9686, \u68ee\u7950\u4e00\u90ce, \u7af9\u5cf6\u5f18, \u6751\u4e95\u5e78\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u7d4c\u904e\u4e2d\u306b\u8d64\u82bd\u7403\u7646\u3092\u767a\u75c7\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u306e\uff11\u4f8b. \u30ea\u30a6\u30de\u30c1\u79d1. \u30002004;32:331-335. (9\u6708)<\/li>\n
    2. \u9577\u53cb\u5b89\u5f18, \u7af9\u5185\u8302, \u7af9\u5185\u4e09\u90ce. \u6700\u8fd14\u5e74\u9593\u306b\u304a\u3051\u308b\u7d50\u6838\u75c779\u4f8b\u306e\u81e8\u5e8a\u7684\u691c\u8a0e.\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c.\u30002004;28:2,133-137. (9\u6708)<\/li>\n
    3. \u6728\u7530\u4fe1\u7ae0, \u6b66\u7530\u5c55\u5e78. \uff2d\u86cb\u767d-\u30ea\u30dd\u86cb\u767d\u8907\u5408\u4f53\u5f62\u6210\u306b\u3088\u308a\u9ad8\u8102\u8840\u75c7\u3092\u6765\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u308b\u4e00\u75c7\u4f8b. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:12-15. (1\u6708)<\/li>\n
    4. \u67d3\u77e2\u3072\u3068\u307f, \u6709\u99ac\u7f8e\u6a39, \u5bae\u8d8a\u67fe\u4e4b, \u8352\u6b66\u516b\u8d77. Auer\u5c0f\u4f53\u69d8\u306e\u5c01\u5165\u7269\u3092\u8a8d\u3081\u305f\u9aa8\u9ac4\u816b\u306e\u4e00\u75c7\u4f8b. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2005;85:19-23. (1\u6708)<\/li>\n
    5. \u9ad8\u57ce\u4e00\u90ce, \u6885\u5317\u90a6\u5f66, \u9db4\u6751\u4f73\u4eba\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u576a\u5185\u535a\u4ec1,\u7530\u4e2d\u5f26\u4e00, \u5ca1\u5c71\u662d\u5f66. \u6025\u6027\u526f\u9f3b\u8154\u708e\u306b\u7d9a\u767a\u3057\u305f\u773c\u7aa9\u8702\u7aa9\u7e54\u708e\u30fb\u80ba\u708e\u306e\uff11\u4f8b. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c.\u30002005;29:64-67. (3\u6708)<\/li>\n<\/ol>\n

      \u3010\u7dcf\u8aac\u3011<\/h4>\n
        \n
      1. \u9577\u53cb\u5b89\u5f18. \u81e8\u5e8a\u306b\u5f79\u7acb\u3064\u547c\u5438\u5668\u75c5\u5b66(1)\u3000\u80ba\u708e\u30fb\u6c17\u9053\u611f\u67d3\u75c7\uff1a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u542b\u3081\u3066. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c.\u30002004;66:36-41. (10\u6708)<\/li>\n
      2. \u9577\u53cb\u5b89\u5f18, \u7af9\u5185\u8302, \u7af9\u5185\u4e09\u90ce. \u7761\u7720\u6642\u7121\u547c\u5438\u75c7\u5019\u7fa4\u306e\u5408\u4f75\u75c7\u306b\u3064\u3044\u3066. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c.\u30002005;67:18-23. (3\u6708)<\/li>\n
      3. \u9577\u53cb\u5b89\u5f18. \u81e8\u5e8a\u306b\u5f79\u7acb\u3064\u547c\u5438\u5668\u75c5\u5b66(2)\u3000\u6297\u83cc\u85ac\u7121\u52b9\u306e\u80ba\u708e. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c.\u30002005;67:35-42. (3\u6708)<\/li>\n<\/ol>\n
        \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

        B. \u767a\u8868<\/h3>\n

        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
          \n
        1. \u677e\u5143\u4fe1\u5f18, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1, \u4e2d\u91cc\u96c5\u5149. \u5faa\u74b0\u5f0f\u6e29\u6cc9\u5165\u6d74\u65bd\u8a2d\u3092\u611f\u67d3\u6e90\u3068\u3057\u305f\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u306e\u753b\u50cf\u6240\u898b\u89e3\u6790. \u7b2c44\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2004. (3\u670831\u65e5-4\u67082\u65e5, \u6771\u4eac\u90fd)<\/li>\n
        2. \u4f50\u3005\u6728\u9686, \u677e\u5143\u4fe1\u5f18, \u5ca1\u5c71\u662d\u5f66, \u4e2d\u91cc\u96c5\u5149, \u576a\u5185\u535a\u4ec1. \u5faa\u74b0\u5f0f\u6e29\u6cc9\u5165\u6d74\u65bd\u8a2d\u3092\u611f\u67d3\u6e90\u3068\u3057\u305f\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u306e\u81e8\u5e8a\u7684\u89e3\u6790. \u7b2c44\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2004. (3\u670831\u65e5-4\u67082\u65e5, \u6771\u4eac\u90fd)<\/li>\n
        3. \u53e4\u57ce\u771f\u79c0\u5b50, \u4e45\u4fdd\u4fca\u82f1, \u5c0f\u8c37\u5bcc\u7537, \u6885\u6728\u4e00\u7f8e, \u5e02\u5834\u6d0b\u4e09. \u7532\u72b6\u817a\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\uff0d\u30bc\uff08TPO\uff09\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3057\u305f\u5148\u5929\u6027\u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7\u306e2\u5bb6\u7cfb. \u7b2c107\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2004. (4\u6708, \u5ca1\u5c71\u770c)<\/li>\n
        4. \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66, \u677e\u5143\u4fe1\u5f18, \u9234\u6728\u6cc9, \u6cb3\u91ce\u559c\u7f8e\u5b50, \u4e2d\u91cc\u96c5\u5149, \u576a\u5185\u535a\u4ec1. \u6e29\u6cc9\u65bd\u8a2d\u30ec\u30b8\u30aa\u30cd\u30e9\u96c6\u56e3\u611f\u67d3\u80ba\u708e\u75c7\u4f8b\u306b\u304a\u3051\u308b\u7d30\u83cc\u5b66\u7684\u691c\u8a0e. \u7b2c78\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2004. (4\u6708, \u6771\u4eac\u90fd)<\/li>\n
        5. \u9ad8\u57ce\u4e00\u90ce, \u68ee\u7950\u4e00\u6717, \u7530\u4e2d\u5f26\u4e00, \u4f50\u3005\u6728\u9686, \u6751\u4e95\u5e78\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u30eb\u30fc\u30d7\u30b9\u814e\u708e\u306b\u5bfe\u3059\u308b\u30b7\u30af\u30ed\u30db\u30b9\u30d5\u30a1\u30df\u30c9\u9759\u6ce8\u7642\u6cd5\u306e\u691c\u8a0e. \u7b2c48\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a. 2004. (4\u6708, \u5ca1\u5c71\u770c)<\/li>\n
        6. \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u68ee\u7950\u4e00\u6717, \u4f50\u3005\u6728\u9686, \u6751\u4e95\u5e78\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u30b7\u30af\u30ed\u30db\u30b9\u30d5\u30a1\u30df\u30c9\u306b\u3088\u308a\u96e3\u6cbb\u6027\u4e0b\u817f\u6f70\u760d\u304c\u6539\u5584\u3057\u305f\u76ae\u819a\u578b\u7d50\u7bc0\u6027\u591a\u767a\u52d5\u8108\u708e\u306e\uff11\u4f8b.\u7b2c48\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a. 2004. (4\u6708, \u5ca1\u5c71\u770c)<\/li>\n
        7. \u7530\u4e2d\u5f26\u4e00, \u68ee\u7950\u4e00\u6717, \u7af9\u5cf6\u5f18, \u9ed2\u6728\u660c\u5e78, \u9ad8\u57ce\u4e00\u90ce, \u4f50\u3005\u6728\u9686, \u6751\u4e95\u5e78\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u82e5\u5e74\u8005\u306b\u767a\u75c7\u3057\u305f\u80ba\u597d\u9178\u7403\u6027\u8089\u82bd\u816b\u75c7\u306e\u4e00\u4f8b. \u7b2c52\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\u6625\u5b63\u5b66\u4f1a. 2004. (6\u6708, \u798f\u5ca1\u770c)<\/li>\n
        8. \u9ad8\u57ce\u4e00\u90ce, \u4e2d\u6751\u61b2\u4e00, \u68ee\u7950\u4e00\u6717, \u7530\u4e2d\u5f26\u4e00, \u4f50\u3005\u6728\u9686, \u6751\u4e95\u5e78\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u80ba\u6027\u80a5\u5927\u6027\u9aa8\u95a2\u7bc0\u75c7\u3092\u5408\u4f75\u3057\u305f\u539f\u767a\u6027\u80ba\u817a\u764c\u306e\u4e00\u4f8b. \u7b2c52\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\u6625\u5b63\u5b66\u4f1a. 2004. (6\u6708, \u798f\u5ca1\u770c)<\/li>\n
        9. Yamaguchi T, Ito S, Kashige N, Takechi S, Nomura H. The chemical reactivities of dihydropyrazine derived from amino sugar. XXIst European Colloquium on Heterocyclic Chemistry. 2004. (September, Sopron, Hungary)<\/li>\n
        10. \u8352\u6b66\u516b\u8d77, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u91ce\u6751\u5275, \u5ca1\u5c71\u662d\u5f66, \u7530\u6751\u548c\u592b. \u7532\u72b6\u817a\u816b\u760d\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306eCD26\/DPPIV\u306b\u3064\u3044\u3066. \u7b2c51\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u7dcf\u4f1a. 2004. (9\u6708, \u6771\u4eac\u90fd)<\/li>\n
        11. \u6885\u6728\u4e00\u7f8e, \u8352\u6b66\u516b\u8d77, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u7532\u72b6\u817a\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\u5206\u5b50\u7570\u5e38\u306e\u89e3\u6790\u306b\u304a\u3051\u308b\uff11\u5869\u57fa\u591a\u578b\u306e\u6709\u7528\u6027. \u7b2c51\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u7dcf\u4f1a. 2004. (9\u6708, \u6771\u4eac\u90fd)<\/li>\n
        12. \u9db4\u6751\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u6728\u6751\u53cb\u662d, \u5c71\u672c\u7ae0\u4e8c\u90ce, \u5bae\u7530\u7fa9\u53f2, \u6885\u5317\u90a6\u5f66, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. SLE\u306b\u5408\u4f75\u3057\u305f\u86cb\u767d\u6f0f\u51fa\u6027\u80c3\u8178\u75c7\u306b, Helicobacter pylori(HP)\u9664\u83cc\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u4e00\u4f8b. \u7b2c28\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2004. (9\u6708, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02)<\/li>\n
        13. \u9ad8\u57ce\u4e00\u90ce, \u4e2d\u6751\u61b2\u4e00, \u6885\u5317\u90a6\u5f66, \u9db4\u6751\u4f73\u4eba\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u7530\u4e2d\u5f26\u4e00, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1. \u539f\u767a\u6027\u80ba\u764c\u306b\u5408\u4f75\u3057\u305f\u80ba\u6027\u80a5\u5927\u6027\u9aa8\u95a2\u7bc0\u75c7\u306e\u4e00\u4f8b. \u7b2c28\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2004. (9\u6708, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02)<\/li>\n
        14. \u91ce\u6751\u3000\u5275, \u5ca1\u5c71\u662d\u5f66. \u7cd6\u7531\u6765dihydropyrazine\u985e\u306e\u7d30\u80de\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u7cfb\u306b\u53ca\u307c\u3059\u4f5c\u7528\u306b\u3064\u3044\u3066\u306e\u89e3\u6790. \u7b2c63\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a. 2004. (9\u6708, \u798f\u5ca1\u770c)<\/li>\n
        15. \u6728\u7530\u4fe1\u7ae0, \u6b66\u7530\u5c55\u5e78. \uff2d\u86cb\u767d-\u30ea\u30dd\u86cb\u767d\u8907\u5408\u4f53\u5f62\u6210\u306b\u3088\u308a\u9ad8\u8102\u8840\u75c7\u3092\u6765\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u308b\u4e00\u75c7\u4f8b. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        16. \u7af9\u30ce\u5185\u535a\u4e4b, \u5150\u7389\u5efa. \u30de\u30cb\u30e5\u30a2\u30eb\u30dd\u30ea\u30d6\u30ec\u30f3\u6cd5\u3092\u4f75\u7528\u3057\u305f\uff2d\uff34\uff33\u6cd5\u306b\u3088\u308b\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u6709\u7528\u6027. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        17. \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u83c5\u6587\u6075, \u6885\u6728\u4e00\u7f8e, \u5cf6\u7530\u96c5\u5df3. \u672c\u9662\u306b\u304a\u3051\u308b\u7dd1\u81bf\u83cc\u5206\u96e2\u682a\u306e\u611f\u53d7\u6027\u52d5\u5411. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        18. \u5965\u91ce\u3081\u3050\u307f, \u67ff\u5143\u7531\u9999, \u4e95\u4e0a\u6b66\u5fd7, \u5b88\u7530\u653f\u5ba3, \u68ee\u5c71\u6676\u5b50, \u8352\u6b66\u516b\u8d77. \uff24\u30c0\u30a4\u30de\u30fc\u8a66\u85ac\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        19. \u67ff\u5143\u7531\u9999, \u5965\u91ce\u3081\u3050\u307f, \u4e95\u4e0a\u6b66\u5fd7, \u5b88\u7530\u653f\u5ba3, \u68ee\u5c71\u6676\u5b50, \u8352\u6b66\u516b\u8d77. \u8840\u6027\u7d30\u80de\u8a3a\u6750\u6599\u306b\u304a\u3051\u308b\u6a19\u672c\u4f5c\u88fd\u6cd5\u306e\u691c\u8a0e. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        20. \u67d3\u77e2\u3072\u3068\u307f, \u6709\u99ac\u7f8e\u6a39, \u5bae\u8d8a\u67fe\u4e4b, \u8352\u6b66\u516b\u8d77. Auer\u5c0f\u4f53\u69d8\u306e\u5c01\u5165\u7269\u3092\u8a8d\u3081\u305f\u9aa8\u9ac4\u816b\u306e\u4e00\u75c7\u4f8b. \u7b2c39\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2004. (10\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        21. \u9ad8\u6797\u79c0\u6b21, \u6885\u6728\u4e00\u7f8e, \u6728\u6751\u4e8c\u90ce, \u5ca1\u5c71\u662d\u5f66, \u52a0\u85e4\u79c0\u6a39. hobbit\u30de\u30a6\u30b9\u306e\u539f\u56e0\u907a\u4f1d\u5b50\u306f\u7532\u72b6\u817a\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\uff08TPO\uff09\u3067\u3042\u308b. \u7b2c21\u56de\u65e5\u672c\u75be\u60a3\u30e2\u30c7\u30eb\u5b66\u4f1a\u7dcf\u4f1a. 2004. (11\u6708, \u4eac\u90fd\u5e9c)<\/li>\n
        22. \u91ce\u6751\u3000\u5275, \u6b66\u77e5\u9032\u58eb, \u5cf0\u677e\u4fca\u592b, \u5ca1\u5c71\u662d\u5f66, \u5c71\u53e3\u5fe0\u654f. \u30d2\u30c8\u767d\u8840\u75c5\u7531\u6765\u7d30\u80de\u682aK-562\u306b\u5bfe\u3059\u308b\u7cd6\u7531\u6765dihydropyrazine\u985e\u306e\u4f5c\u7528\u306b\u3064\u3044\u3066\u306e\u89e3\u6790. \u7b2c27\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a. 2004. (12\u6708, \u5175\u5eab\u770c\u795e\u6238\u5e02)<\/li>\n
        23. \u6b66\u77e5\u9032\u58eb, \u91ce\u6751\u3000\u5275, \u5cf0\u677e\u4fca\u592b, \u5c71\u53e3\u5fe0\u654f. \u7cd6\u7531\u6765\u306e\u5909\u5316\u751f\u6210\u7269\u30b8\u30d2\u30c9\u30ed\u30d4\u30e9\u30b8\u30f3\u985e\u306b\u3088\u308b\u7a81\u7136\u5909\u7570\u90e8\u4f4d\u306e\u540c\u5b9a. \u7b2c27\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a. 2004. (12\u6708, \u5175\u5eab\u770c\u795e\u6238\u5e02)<\/li>\n
        24. \u8352\u6b66\u516b\u8d77, \u5927\u91ce\u62db\u4f38, \u4f50\u85e4\u4fe1\u4e5f, \u65e5\u91ce\u6d66\u96c4\u4e4b, \u4e38\u585a\u6d69\u52a9, \u4e0b\u4e4b\u6bb5\u79c0\u5b9f, \u5ca1\u5c71\u662d\u5f66. \u4f53\u8154\u6db2\u7d30\u80de\u8a3a\u306b\u304a\u3051\u308b\u8a3a\u65ad\u7684 pitfall. \u7b2c21\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u5bae\u5d0e\u652f\u90e8\u7dcf\u4f1a. 2005. (2\u6708, \u5bae\u5d0e\u770c)<\/li>\n
        25. \u6885\u6728\u4e00\u7f8e, \u8352\u6b66\u516b\u8d77, \u5c71\u672c\u6210\u90ce, \u7530\u4e2d\u5f26\u4e00, \u91ce\u6751\u5275, \u5c71\u672c\u5fb9, \u68b6\u7530 \u82b3\u5f18, \u5ca1\u5c71\u662d\u5f66. \u7532\u72b6\u817a\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\u907a\u4f1d\u5b50\u306b\u65b0\u305f\u306a\u30ca\u30f3\u30bb\u30f3\u30b9\u5909\u7570\u3068\u5869\u57fa\u7f6e\u63db\u304c\u691c\u51fa\u3055\u308c\u305f\u5148\u5929\u6027\u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7\u306e\u5bb6\u7cfb. \u7b2c49\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2005. (2\u6708, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02)<\/li>\n<\/ol>\n

          \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n
            \n
          1. \u5ca1\u5c71\u662d\u5f66, \u4f50\u3005\u6728\u9686, \u677e\u5143\u4fe1\u5f18, \u7027\u53e3\u4fca\u4e00, \u9234\u6728\u6cc9, \u52a0\u85e4\u8cb4\u5f66, \u524d\u7530\u3072\u3068\u307f. \u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u306e\u96c6\u56e3\u767a\u751f\u4e8b\u4f8b\u3068\u81e8\u5e8a\u75c7\u4f8b 1)\u96c6\u56e3\u767a\u751f\u4e8b\u4f8b \u2462\u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u5faa\u74b0\u5f0f\u6e29\u6cc9\u65bd\u8a2d\u4e8b\u4f8b. \u5316\u5b66\u7642\u6cd5\u306e\u9818\u57df. 2004;20:67-69.<\/li>\n
          2. \u5ca1\u5c71\u662d\u5f66. \u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u81e8\u5e8a\u5206\u96e2\u682a\u306b\u5bfe\u3059\u308b\u6297\u83cc\u85ac\u611f\u53d7\u6027\u306e\u52d5\u5411. \u5168\u56fd\u90fd\u9053\u5e9c\u770c\u5225\u85ac\u5264\u611f\u53d7\u6027\u5831\u544a\uff0f\u5bae\u5d0e\u7de8.\u30002004. (10\u6708)<\/li>\n
          3. \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u7d30\u80de\u30af\u30ed\u30fc\u30ca\u30ea\u30c6\u30a3\u306f\u3069\u306e\u3088\u3046\u306b\u6c7a\u307e\u308b\u304b. \u5e73\u621016\u5e74\u5ea6\u6587\u90e8\u79d1\u5b66\u7701\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\u304c\u3093\u7814\u7a76\u306b\u4fc2\u308f\u308b\u7279\u5b9a\u9818\u57df\u7814\u7a76\u300cATL\u767a\u75c7\u9ad8\u5371\u967a\u7fa4\u306e\u540c\u5b9a-\u767a\u75c7\u4e88\u9632\u3092\u76ee\u6307\u3057\u3066\u300d\u7814\u7a76\u73ed\u7b2c\uff12\u56de\u73ed\u4f1a\u8b70. 2005. (1\u6708, \u548c\u6b4c\u5c71\u770c)<\/li>\n<\/ol>\n
            \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

            C. \u305d\u306e\u4ed6<\/h3>\n
            \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

            D. \u7279\u8a31\u51fa\u9858<\/h3>\n

            –<\/p>\n

            \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/div>\n

            \u5185\u8a33\u6570<\/h2>\n

            A.\u8ad6\u6587\uff1a\u8457\u66f8(0)\u3001\u539f\u8457\uff0814\uff09\u3001\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\uff085\uff09\u3001\u7dcf\u8aac\uff083\uff09\u3000B.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0825\uff09\u3001\u305d\u306e\u4ed6\uff083\uff09 C.\u305d\u306e\u4ed6\uff081\uff09\u3000D.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

            A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 – \u3010\u539f\u8457\u3011 Takechi S, Yamaguchi T, Nomura H, Minematsu T, Nakayama T. Growth inhibition and mutag […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/223"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=223"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/223\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=223"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}